These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The diabetic brain and cognition. Riederer P; Korczyn AD; Ali SS; Bajenaru O; Choi MS; Chopp M; Dermanovic-Dobrota V; Grünblatt E; Jellinger KA; Kamal MA; Kamal W; Leszek J; Sheldrick-Michel TM; Mushtaq G; Meglic B; Natovich R; Pirtosek Z; Rakusa M; Salkovic-Petrisic M; Schmidt R; Schmitt A; Sridhar GR; Vécsei L; Wojszel ZB; Yaman H; Zhang ZG; Cukierman-Yaffe T J Neural Transm (Vienna); 2017 Nov; 124(11):1431-1454. PubMed ID: 28766040 [TBL] [Abstract][Full Text] [Related]
27. The Comorbidity of Bipolar Disorder and Migraine: The Role of Inflammation and Oxidative and Nitrosative Stress. da Costa SC; Passos IC; Réus GZ; Carvalho AF; Soares JC; Quevedo J Curr Mol Med; 2016; 16(2):179-86. PubMed ID: 26812917 [TBL] [Abstract][Full Text] [Related]
28. Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. Kamintsky L; Cairns KA; Veksler R; Bowen C; Beyea SD; Friedman A; Calkin C Neuroimage Clin; 2020; 26():102049. PubMed ID: 31718955 [TBL] [Abstract][Full Text] [Related]
29. Refractory bipolar disorder and neuroprogression. da Costa SC; Passos IC; Lowri C; Soares JC; Kapczinski F Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():103-10. PubMed ID: 26368941 [TBL] [Abstract][Full Text] [Related]
31. Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction. Keane KN; Cruzat VF; Carlessi R; de Bittencourt PI; Newsholme P Oxid Med Cell Longev; 2015; 2015():181643. PubMed ID: 26257839 [TBL] [Abstract][Full Text] [Related]
32. Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Rosales-Corral S; Tan DX; Manchester L; Reiter RJ Oxid Med Cell Longev; 2015; 2015():985845. PubMed ID: 25815110 [TBL] [Abstract][Full Text] [Related]
33. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers. Nasoohi S; Parveen K; Ishrat T J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683 [TBL] [Abstract][Full Text] [Related]
34. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Rizzo LB; Costa LG; Mansur RB; Swardfager W; Belangero SI; Grassi-Oliveira R; McIntyre RS; Bauer ME; Brietzke E Neurosci Biobehav Rev; 2014 May; 42():157-69. PubMed ID: 24548785 [TBL] [Abstract][Full Text] [Related]
35. Cognitive deficits in bipolar disorders: Implications for emotion. Lima IMM; Peckham AD; Johnson SL Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773 [TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Bora E; Özerdem A Psychol Med; 2017 Dec; 47(16):2753-2766. PubMed ID: 28585513 [TBL] [Abstract][Full Text] [Related]
38. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Berk M Int J Neuropsychopharmacol; 2009 May; 12(4):441-5. PubMed ID: 18922203 [No Abstract] [Full Text] [Related]
39. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Moylan S; Maes M; Wray NR; Berk M Mol Psychiatry; 2013 May; 18(5):595-606. PubMed ID: 22525486 [TBL] [Abstract][Full Text] [Related]
40. Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline. Walker JM; Harrison FE Nutrients; 2015 Sep; 7(9):7332-57. PubMed ID: 26340637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]